AP

AVANTECA Partners

Europe, Basel-Stadt, Switzerland, Basel

Description

AVANTECA Partners is an asset management company investing in early-stage Life Science companies.

Investor Profile

AVANTECA Partners has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (83%)
  • Series Unknown (17%)

Country Focus

  • Switzerland (67%)
  • Spain (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Public Safety
  • Security
  • Nanotechnology
  • Pharmaceutical
  • Medical Device
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AVANTECA Partners frequently co-invest with?

Co-Investments: 1
SS
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
IAG Capital Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
H. Hentsch Asset Management
Europe, Vaud, Switzerland, Nyon
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
OCCIDENT
Europe, Bayern, Germany, Munich
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
NC
Europe, Madrid, Spain, Madrid
Co-Investments: 1
GG
Europe, Zug, Switzerland, Cham
Co-Investments: 1

What are some of recent deals done by AVANTECA Partners?

Onena Medicines

Donostia-san Sebastián, Pais Vasco, Spain

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

BiotechnologyHealth CareMedical Device
Series UnknownOct 31, 2023
Amount Raised: $4,065,599
Bearmind

Lausanne, Vaud, Switzerland

Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.

Public SafetySecurity
SeedJul 18, 2023
Amount Raised: $816,059
Bearmind

Lausanne, Vaud, Switzerland

Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.

Public SafetySecurity
SeedMar 7, 2023
Amount Raised: $1,379,571
Invasight

Zürich, Zurich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

BiopharmaBiotechnologyHealth Care
SeedJun 7, 2022
Amount Raised: $4,621,931
Nanoligent

Barcelona, Catalonia, Spain

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

BiotechnologyNanotechnologyOncologyPharmaceutical
SeedFeb 3, 2022
Amount Raised: $1,143,555
Oncobit

Zürich, Zurich, Switzerland

Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.

BiotechnologyHealth CareHealth DiagnosticsOncology
SeedApr 30, 2021
Amount Raised: $2,519,695